本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Soligenix, Inc.

2.06
+0.06003.00%
盘后2.00-0.0600-2.91%19:57 EDT
成交量:11.20万
成交额:22.92万
市值:650.05万
市盈率:-0.41
高:2.11
开:2.08
低:1.96
收:2.00
数据加载中...

公司资料

公司名字:
Soligenix, Inc.
交易所:
NASDAQ
成立时间:
1987
员工人数:
15
公司地址:
29 Emmons Drive,Suite B-10,Princeton,New Jersey,United States
邮编:
08540
电话:
传真:
609 452 6467
简介:
Soligenix, Inc.成立于1987年,是一家临床阶段生物制药公司,专注于开发产品,治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用(仍然是一个未满足的医疗需求),以及开发多种生物防御疫苗和疗法。

董事

名称
职位
Christopher J. Schaber
Chairman of the Board, Chief Executive Officer and President
Diane L. Parks
Director
Gregg A. Lapointe
Director
Jerome B. Zeldis
Director
Robert J. Rubin
Director

股东

名称
职位
Christopher J. Schaber
Chairman of the Board, Chief Executive Officer and President
Jonathan Guarino
Chief Financial Officer, Senior Vice President and Corporate Secretary
Oreola Donini
Chief Scientific Officer and Senior Vice President
Richard Straube
Chief Medical Officer and Senior Vice President